C12H9F3N2O2
270.21 g/mol
APIDanger
Leflunomide
CAS75706-12-6EC616-254-6
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Leflunomide is an immunosuppressive compound used as an active pharmaceutical ingredient in disease-modifying antirheumatic drug (DMARD) formulations. It functions by inhibiting dihydroorotate dehydrogenase, affecting pyrimidine synthesis.
pharmaceutical raw material for immunosuppressive formulationsactive pharmaceutical ingredient in DMARD manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 75706-12-6
Related Compounds
ReferenceSame Category
Folic acid dihydrate
CAS75708-92-8
pharmaceutical raw material
ReferenceSame Category
Afamelanotide
CAS75921-69-6
pharmaceutical raw material
ReferenceSame Category
Enclomiphene citrate
CAS7599-79-3
pharmaceutical raw material
ReferenceSame Category
Triamcinolone acetonide
CAS76-25-5
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
InChIKey
VHOGYURTWQBHIL-UHFFFAOYSA-N
SMILES
CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
Synonyms (42)
- SULOL
- Leflunomida [INN-Spanish]
- Leflunomide (JAN/USP/INN)
- Leflunomide for peak identification, European Pharmacopoeia (EP)
- Leflunomide, European Pharmacopoeia (EP)
- Leflunomide, United States Pharmacopeia (USP)
- Leflunomidum [INN-Latin]
- Lefunomide [Inn-Spanish]
- Arabloc
- Arava
- Arava (TN)
- LEFLUNOMIDE [MART.]
- Leflunomida
- Leflunomide (Standard)
- Leflunomide CRS
- Leflunomide ratiopharm
- Leflunomide teva
- Leflunomide winthrop
- Leflunomidum
- Repso
- SU 101 (pharmaceutical)
- leflunomide
- leflunomide medac
- lefunamide